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Behavioral/Systems/Cognitive

Activation of Metabotropic Glutamate Receptor 5 in the
Amygdala Modulates Pain-Like Behavior
Benedict J. Kolber,1 Michael C. Montana,1,2 Yarimar Carrasquillo,1 Jian Xu,3 Stephen F. Heinemann,3 Louis J. Muglia,4
and Robert W. Gereau IV1,2
1

Washington University Pain Center, Department of Anesthesiology and 2Program in Neuroscience, Washington University, St. Louis, Missouri 63110, 3The
Salk Institute for Biological Studies, Molecular Neurobiology Laboratory, La Jolla, California 92037, and 4Department of Pediatrics and Molecular
Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232

The central nucleus of the amygdala (CeA) has been identified as a site of nociceptive processing important for sensitization induced by
peripheral injury. However, the cellular signaling components underlying this function remain unknown. Here, we identify metabotropic
glutamate receptor 5 (mGluR5) as an integral component of nociceptive processing in the CeA. Pharmacological activation of mGluRs
with (R,S)-3,5-dihydroxyphenylglycine (DHPG) in the CeA of mice is sufficient to induce peripheral hypersensitivity in the absence of
injury. DHPG-induced peripheral hypersensitivity is reduced via pharmacological blockade of mGluR5 or genetic disruption of mGluR5.
Furthermore, pharmacological blockade or conditional deletion of mGluR5 in the CeA abrogates inflammation-induced hypersensitivity,
demonstrating the necessity of mGluR5 in CeA-mediated pain modulation. Moreover, we demonstrate that phosphorylation of
extracellular-signal regulated kinase 1/2 (ERK1/2) is downstream of mGluR5 activation in the CeA and is necessary for the full expression
of peripheral inflammation-induced behavioral sensitization. Finally, we present evidence of right hemispheric lateralization of mGluR5
modulation of amygdalar nociceptive processing. We demonstrate that unilateral pharmacological activation of mGluR5 in the CeA
produces distinct behavioral responses depending on whether the right or left amygdala is injected. We also demonstrate significantly
higher levels of mGluR5 expression in the right amygdala compared with the left under baseline conditions, suggesting a potential
mechanism for right hemispheric lateralization of amygdala function in pain processing. Together, these results establish an integral role
for mGluR5 and ERK1/2 in nociceptive processing in the CeA.

Introduction
The amygdala is selectively activated in both humans and rodents
during pain (Schneider et al., 2001; Lu et al., 2004; Han and
Neugebauer, 2005; Carrasquillo and Gereau, 2007; Ikeda et al.,
2007). Within the amygdala, the central nucleus (CeA) is well
positioned to regulate nociceptive processing via input through
the spino-parabrachio-amygdaloid pathway or through the basolateral nucleus of the amygdala (BLA) (Neugebauer et al.,
2004). Within the CeA, the laterocapsular division (CeLC) has
been identified as a putative pain regulatory center, in part because of the sensitivity of neurons within this region to noxious
stimuli.
After induction of painful arthritis in rats, neurons in the
CeLC exhibit increased baseline firing and an enhanced response
to noxious stimuli (Li and Neugebauer, 2004). In addition, actiReceived March 9, 2010; revised April 28, 2010; accepted May 7, 2010.
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vation of CeLC group I metabotropic glutamate receptors
(mGluR1 and mGluR5) with the selective group I mGluR agonist
( R, S)-3,5-dihydroxyphenylglycine (DHPG) potentiates the response of CeLC neurons to painful stimuli (Neugebauer et al.,
2003; Li and Neugebauer, 2004). These data suggest that group
I mGluRs in the CeA could be critical to nociceptive processing in this nucleus. However, the specific contributions of
mGluR1 and mGluR5, as well as those of downstream regulators, are unknown.
mGluR1 and mGluR5 are expressed throughout the pain neuroaxis (Ryo et al., 1993; Romano et al., 1995) and have been
identified as important molecular components of nociception
(Bhave et al., 2001; Karim et al., 2001b; Varney and Gereau, 2002;
Li and Neugebauer, 2004; Han and Neugebauer, 2005; Hu et al.,
2007; Ansah et al., 2009). Activation of mGluR5 can lead to
ERK1/2 (extracellular-signal regulated kinase 1/2) phosphorylation (activation) via the intracellular MAPK (mitogen-activated
protein kinase) cascade (Karim et al., 2001a). This signaling cascade has been shown to be critical for sensitization of spinal dorsal horn neurons (Hu and Gereau, 2003; Hu et al., 2003), a
mechanism underlying enhancement of pain-like behavior after
peripheral inflammation (Karim et al., 2001a; Adwanikar et al.,
2004). In the context of peripheral inflammation, activation of
ERK in the CeA of mice occurs in a lateralized manner, with more
ERK activation occurring in the right amygdala compared with the
left (Carrasquillo and Gereau, 2008), and is necessary for
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inflammation-induced mechanical hypersensitivity (Carrasquillo
and Gereau, 2007). Furthermore, activation of ERK in the amygdala induces pain-like behavior in the absence of any peripheral
injury, a phenomenon that may have important implications for
pain syndromes that are not associated with an identified tissue
injury. However, at this point the role of mGluR5 in this process
is unknown.
In the present study, we sought to test the hypothesis that
mGluR5 activation and downstream ERK1/2 activation in the
CeA are necessary and sufficient for nociceptive behavioral sensitization. Utilizing both pharmacological and genetic techniques, we demonstrate that right amygdala mGluR5 activation
induces bilateral tactile hypersensitivity and that mGluR5 activation, but not endocrine feedback, is required for the mechanical
hypersensitivity induced by peripheral inflammation. We demonstrate that mGluR5-mediated hypersensitivity is functionally
coupled to and dependent on ERK1/2 activation. Finally, we find
that mGluR5 expression is greater in the right amygdala relative
to the left amygdala.

Materials and Methods
Animals
All mouse protocols were in accordance with National Institutes of
Health guidelines and were approved by the Animal Care and Use Committees of Washington University School of Medicine (St. Louis, MO).
Male mice (all C57BL/6 background) were housed on a 12/12 h light/
dark cycle [lights on at zeitgeber time (ZT) 0] with ad libitum access to
rodent chow and water. Unless otherwise stated, wild-type (WT)
C57BL/6J (The Jackson Laboratory) male mice age 6 – 8 weeks were used
for pharmacological studies.
mGluR5KO. Conventional mGluR5 knock-out (mGluR5 KO) male
mice have been described previously (Jia et al., 1998) and were obtained
from The Jackson Laboratory. For pharmacological testing with
mGluR5 KO mice, cannula verification was done as described below.
GRCeAKO. Mice homozygous for the GRloxP allele were stereotaxically
injected into bilateral CeAs with either lentiviral (LV) vector LV-Ef1␣Cre (GR CeAKO) or LV-Ef1␣-GFP (control mice; where GFP is green
fluorescent protein) as described previously (Kolber et al., 2008). Briefly,
mice were anesthetized and mounted in a stereotaxic frame. A small hole
was drilled over the right and left CeAs (coordinates: 1.25 mm anterior to
bregma; ⫾2.7 mm lateral to midline; 4.7 mm ventral to skull). A 32gauge needle was lowered into the hole and left in place for 1 min before
injection of virus. Infectious viral particles (4 ⫻ 10 5) were injected over 5
min and the needle was left in place for 5 min after injection. All testing in
these mice occurred 2 wk after recovery from surgery. After testing,
brains were sectioned to determine needle targeting and the percentage
of NeuN-positive glucocorticoid receptor (GR)-expressing cells as a
measure of GR disruption in the CeA and nearby BLA. It was previously
determined that GR CeAKO mice have 34.8 ⫾ 1.97% NeuN-positive GRexpressing cells compared with 95.0 ⫾ 0.48% NeuN-positive GRexpressing cells in the CeA of control LV-GFP-injected mice (Kolber et
al., 2008). No significant differences were observed in the BLA in either
LV-Cre or LV-GFP-injected mice.
mGluR5CeAKO. Mice homozygous for the mGluR5loxP allele (Xu et al.,
2009) or WT littermates were used. All animals were injected in the right
amygdala with recombinant lentiviral vector LV-Ef1␣-Cre (LV-Cre)
similarly as described previously (Kolber et al., 2008). Briefly, mice were
anesthetized with a combination ketamine/xylazine anesthetic and
mounted in a stereotaxic frame. A small hole was drilled over the right
CeA (coordinates: 1.25 mm anterior to bregma; 2.7 mm lateral to midline; 4.7 mm ventral to skull). A 32-gauge needle was lowered into the
hole and left in place for 1 min before injection of virus. Infectious viral
particles (4 ⫻ 10 5) were injected over 5 min and the needle was left in
place for 5 min after injection. All testing in these mice occurred 2 wk
after recovery from surgery. After testing, brains were sectioned to determine needle targeting and 1 mm diameter ⫻ 1 mm high punches were
made of the amygdala in two adjacent sections to determine the amount

of mGluR5 disrupted in floxed mice compared with WT mice injected
with LV-Cre. See below for processing of tissue punches.

Surgical procedure for cannula implantation
Mice were deeply anesthetized with a combination ketamine/xylazine
anesthetic and mounted in a stereotaxic frame. Stainless steel guide cannulas (8 mm) were implanted at the CeA (coordinates: 1.25 mm anterior
to bregma; ⫾2.70 mm lateral to midline; 4.2 mm ventral to skull). The
guide cannula was affixed to the skull with two bone screws (Stoelting)
and dental cement. An 8 mm stylet was inserted in the guide cannula to
prevent clogging. Mice recovered for 6 d before further testing. At the end
of experiments, brains were sectioned to verify cannula position and
injection site.

Intra-amygdala drug infusions
Injection procedures. Microinjections were performed as described previously (Carrasquillo and Gereau, 2007). Briefly, injections were performed using a 32-gauge injection cannula that extended 0.5 mm beyond
the tip of the guide cannula. The injection cannula was attached to flexible plastic tubing and a microliter syringe (Hamilton) was used to deliver drugs. A total volume of 0.3 l was infused over a period of 3 min
and the injection cannula was kept in place for an additional 1 min to
allow for drug infusion.
Drugs injected. DHPG (Tocris Bioscience) is a potent agonist that activates both mGluR5 and mGluR1. On the day of the experiment, DHPG
was dissolved in artificial CSF (aCSF) containing the following (in mM):
25 NaHCO3, 122 NaCl, 1.3 CaCl2, 1.2 MgSO4, 3 KCl, and 0.4 KH2PO4,
pH 7.35, to a final stock solution of 5 mM. Stock solution was diluted in
aCSF or aCSF/DMSO to the final concentrations stated in the text.
2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP; Tocris Bioscience) is a selective noncompetitive antagonist of mGluR5. On the day
of the experiment, MPEP was dissolved in aCSF to a final stock solution
of 5 mM. Stock solution was diluted in aCSF to final concentrations stated
in the text. 1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)
butadiene (U0126; Tocris Bioscience) was selected to inhibit ERK
activation. Experiments with U0126 were compared with the-negative
structural control analog 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)
butadiene (U0124). U0126 and U0124 (Tocris Bioscience) were dissolved as described previously (Carrasquillo and Gereau, 2007). U0126
and U0124 were dissolved first in 100% DMSO to a 2⫻ stock solution.
Final dilutions were made to be 50% DMSO/50% aCSF. Dosing of U0126
was determined from our previous work with this drug (Carrasquillo and
Gereau, 2007, 2008). For experiments using combinations of drugs, individual drugs were dissolved at 2⫻ the stated final concentration and
then combined 1:1 with other drug. Unless otherwise stated, aCSF was
used as a vehicle control.

Behavioral testing
All behavioral testing was performed by an experimenter blinded to
pharmacological treatment and genotype and was done between ZT1
and ZT8. Mice were habituated (for ⬎2 h) and tested in 25 ⫻ 25 ⫻ 35 cm
ventilated Plexiglas enclosures with background white noise used to
mask random noise. Mechanical sensitivity was measured using von Frey
filaments (North Coast Medical) as described previously (Fu et al., 2001;
Yang and Gereau, 2003). Each von Frey filament, starting with the smallest, was applied to the mouse hindpaw until bent at 30° for ⬃2 s. The
smallest filament that evoked a paw withdrawal response in at least three
of the five trials was taken as the mechanical threshold for that trial. Three
to five baseline measurements were taken from each hindpaw on the day
before all drug or formalin experiments. The average withdrawal force
was calculated individually for each paw as the baseline. Mechanical
hypersensitivity was calculated by comparing withdrawal thresholds after drug/formalin to baseline withdrawal value. For DHPG, DHPG plus
MPEP, and DHPG plus U0126 experiments, intra-amygdala drug infusions were performed 30 min before mechanical testing. In tests using
formalin-induced mechanical hypersensitivity, 10 l of 2% formalin
(Sigma) solution was injected subcutaneously in the plantar surface of
the right hindpaw. The right hindpaw was chosen for formalin treatment
because previous work from our laboratory (Carrasquillo and Gereau,
2007, 2008) and others (Ji and Neugebauer, 2009) has shown that
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7.4, 1 mM EDTA, 1 mM sodium pyrophosphate,
25 g/ml aprotinin, 25 g/ml leupeptin, 1
g/ml microcystein, 1 mM sodium orthovanadate, and 100 M phenylmethylsulfonyl fluoride; Sigma) using a Dounce homogenizer.
Protein concentrations were determined using
the BCA protein assay kit (Pierce Biotechnology). The levels of ERK activation in the amygdala were measured by Western blotting using
antibodies specific for phosphorylated ERK
(pERK) and total ERK. Total protein (5 g) for
amygdala homogenates was run using 4 –12%
SDS-PAGE (Invitrogen) and transferred to nitrocellulose membranes (Whatman). Blots were
blocked in Odyssey blocking buffer (Licor) for 1 h
and then coincubated in mouse anti-p44/42
B
C
ERK (1:1000, Cell Signaling Technology, Beverly, MA) and rabbit antiphospho-p44/42 ERK
(1:1000; Cell Signaling Technology) primary
antibodies in Odyssey buffer with 0.1% Tween
20 (Sigma) for 1 h at room temperature (RT).
After washing in TBS with 0.1% Tween 20,
blots were incubated in goat anti-rabbit IR800
(1:20,000; Rockland) and goat anti-mouse Alexa 680 (1:20,000 Invitrogen) for 1 h at RT.
Blots were washed and scanned using an Odyssey scanner (Licor). Densitometry of bands
corresponding to ERK1 (p44) and ERK2 (p42)
was performed using Odyssey v3.0 software
(Licor).
Effect of MPEP on formalin-induced ERK1/2
activation. To determine the effects of MPEP
on formalin-induced ERK1/2 activation, intraright amygdala drug infusion was performed
Figure 1. mGluR5 and phosphorylated ERK are expressed in the CeLC. A, Immunoreactivity showing mGluR5 expression (in 2 h after formalin injection and brains were
white) in WT mice (mGluR5 control mice; left) or conventional mGluR5 KO mice (right). No positive signal was seen in mGluR5 KO removed 60 min after drug infusion, which
sections. B, C, Magnified images demonstrate mGluR5 expression in the left (B; in white) and right CeLCs (C, left in white). C, corresponds to 3 h after formalin injection in
Additional panels for the right CeLC demonstrate that mGluR5 (left panel, in white; right panel, in green) and phosphorylated ERK the paw. Brains were sectioned into 1-mmthick coronal sections using an acrylic brain
(middle panel, in white; right panel, in magenta) are expressed in the CeLC of WT mice. Scale bars, 200 m.
matrix (Stoelting) From the two appropriate
sections, amygdala punches (two per side per
inflammation-induced right CeA activation occurs independently of the
animal) were obtained using a custom-made 1 mm punch tool. Activated
side of peripheral inflammation (i.e., right or left side of body). For
ERK1/2 was analyzed as described above by Western blot.
nonpharmacological experiments with mGluR5 KO, mGluR5 CeAKO, and
Protein expression in mGluR5KO and mGluR5CeAKO mice. Brains were
CeAKO
GR
mice, mechanical sensitivity was measured 3 h following inremoved
from mGluR5 KO mice (compared with WT mice) or
traplantar formalin injection. To determine the effects of MPEP on
CeAKO
mGluR5
mice (compared with LV-Cre-injected WT mice) and
formalin-induced mechanical hypersensitivity, intra-amygdala drug insectioned into 1 mm-thick coronal sections. From the two appropriate
fusion was performed 2 h after formalin injection and mechanical threshsections, amygdala punches (two per side per animal) were processed as
olds were measured 1 h after intra amygdala drug infusion, which
described above with ice-cold homogenization buffer (20 mM Tris-HCl,
corresponds to 3 h after formalin injection in the paw.
pH 7.4, 1 mM EDTA, 1 mM sodium pyrophosphate, 25 g/ml aprotinin,
The formalin test to measure spontaneous behaviors following forma25 g/ml leupeptin, and 100 M phenylmethylsulfonyl fluoride). The
lin injection was performed as described previously (Bhave et al., 2001).
levels of mGluR5 or GR in the left or right amygdala were measured by
mGluR5 CeAKO and control mice were videotaped following intradermal
formalin injection and analyzed offline for nociceptive behavior (defined
Western blotting using antibodies specific for mGluR5 or GR and the
as licking, lifting, and flinching of the injected paw) in 5 min bins. The
loading control protein ␤-tubulin. Total protein (3–5 g) for amygdala
first phase of spontaneous behavior was defined as 0 –10 min after forhomogenates was run using 4 –12% SDS-PAGE and transferred to nitromalin, and then the second phase of testing was defined as 10 –35 min
cellulose membranes. For mGluR5 Western blotting, blots were blocked
after formalin injection.
in Odyssey blocking buffer for 1 h and then coincubated in mouse anti␤-tubulin (1:10,000; Sigma) and rabbit anti-mGluR5 (1:1000; Millipore)
Western blotting
primary
antibodies in Odyssey buffer with 0.1% Tween 20 for 1 h at RT.
All plots of Western quantification are normalized to the control (e.g.,
For GR Western blotting, blots were blocked in Odyssey blocking buffer
vehicle) left amygdala level of protein and are expressed as “fold control.”
for 1 h and then coincubated in anti-␤-tubulin and rabbit anti-GR (1:
DHPG and DHPG/U0126 ERK1/2 activation. Following intra1000; Santa Cruz Biotechnology) primary antibodies in Odyssey buffer
amygdala infusion of 0.1 nmol of DHPG alone (compared with vehicle)
with 0.1% Tween 20 overnight at 4°C. After washing in TBS with 0.1%
or DHPG plus U0126 (compared with DHPG plus U0124), brains were
Tween 20, blots were incubated in goat anti-mouse IR800 (1:20,000) and
removed and sectioned into 1-mm-thick coronal sections using an
goat anti-rabbit Alexa 680 (1:20,000) for 1 h at RT. Blots were washed and
acrylic brain matrix (Stoelting). From the two appropriate sections,
scanned using an Odyssey scanner. Densitometry of bands correspondamygdala punches (two per side per animal) were obtained using a
ing to mGluR5/GR and ␤-tubulin was performed using Odyssey softcustom-made 1 mm punch tool. Samples were frozen on dry ice and then
ware. Each mGluR5 or GR value was divided by the pixel value for that
homogenized in ice-cold homogenization buffer (20 mM Tris-HCl, pH

A
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sample’s ␤-tubulin value and then normalized
to the left amygdala control.

Immunohistochemistry
DHPG-induced ERK activation. Thirty minutes
after intra-amygdala infusion of 0.1 nmol of
DHPG (compared with vehicle), mice were
deeply anesthetized with 2.5% Avertin anesthesia and then perfused transcardially with
PBS (37°C), followed by 100 ml of ice-cold 4%
paraformaldehyde (PFA) solution in PBS. The
brain was dissected and postfixed in PFA overnight at 4°C. After cryoprotection in 30% sucrose, coronal sections (30 m) were obtained
on a cryostat and stored in PBS at 4°C until
immunostaining. Sections were rinsed in PBS,
incubated in 10% MeOH/0.3% H2O2 in PBS
for 30 min at RT, and blocked in 1% normal
goat serum (NGS) (Vector Laboratories) with
0.02% Triton X-100 for 1 h at RT. Sections
were incubated overnight at 4°C in rabbit antiphospho-p44/42 ERK antibody (1:1000; Cell
Signaling Technology) in blocking solution.
Sections were rinsed in PBS with 0.2% Triton
X-100 and incubated in goat anti-rabbit biotinylated secondary antibody (1:200; Vector Figure 2. Activation of amygdala mGluR5 induces mechanical hypersensitivity. A, B, DHPG, a selective group I mGluR agonist,
Laboratories) in blocking solution for 120 min injected into the right amygdala (0.01 nmol, n ⫽ 8; 0.1 nmol, n ⫽ 8) causes significant mechanical hypersensitivity 30 min after
at RT. Sections were rinsed in PBS with 0.2% injection in both the left (A) and right (B) paws compared with vehicle-treated mice (n ⫽ 8). C, D, DHPG injected into the left
Triton X-100 and incubated in an avidin- amygdala (n ⫽ 11) causes mechanical hypersensitivity in the right (D) but not in the left (C) paw compared with vehicle-treated
biotin complex (Vector Laboratories) for 60 mice (n ⫽ 10). Gray areas in brain illustrations are representative of WT mGluR5 expression. Data are expressed as mean ⫾ SEM.
min at RT. Sections were rinsed in PBS and Repeated-measures ANOVA with Bonferroni post-test: **p ⬍ 0.01, ***p ⬍ 0.001, compared with vehicle-treated group at
incubated in a Cy-3-conjugated tyramide signal specified time point; ##p ⬍ 0.01, ###p ⬍ 0.001, compared with baseline for specified group.
amplification reagent (PerkinElmer). Immunohistochemical sections were wet mounted
is expressed in the CeLC, the putative nociceptive amygdala (Fig.
and visualized using a Nikon Eclipse 80i fluorescent microscope. Note
1 B, C), with activated ERK1/2 (Fig. 1C). After identifying the
that we typically see some amount of pERK immunofluoresence in naive
presence of mGluR5 in the CeLC, we tested the hypothesis that
animals (Carrasquillo and Gereau, 2007).
mGluR5 activation in the amygdala is sufficient to induce memGluR5 and ERK in WT and mGluR5KO mice. Mice were deeply aneschanical hypersensitivity.
thetized and processed as above. Sections were first stained for phosphorylated ERK as described above. Following ERK staining, sections were
Intra-amygdala mGluR5 activation induces
then blocked in 3% NGS with 0.3% Triton X-100 for 1 h at RT. Sections
were incubated overnight at 4°C in anti-mGluR5 antibody (1:1500) in
mechanical hypersensitivity
blocking solution. Sections were rinsed in PBS with 0.2% Triton X-100
We used the von Frey test to determine whether activation of CeA
and incubated in goat anti-rabbit Alexa 488-conjugated secondary antigroup I mGluRs was sufficient to induce peripheral mechanical
body (1:200, Invitrogen) in blocking solution for 60 min at RT. Immuhypersensitivity. The von Frey test is an established method for
nohistochemical sections were wet mounted and visualized using a
determining mechanical sensitivity in mice (Fu et al., 2001).
Nikon Eclipse 80i fluorescent microscope.

Data analysis

Results are expressed as means ⫾ SEM. Unpaired Student’s t tests were
used to compare pairs of means. To compare lateralization of protein,
paired Student’s t tests were used to compare two means from the same
group of mice (e.g., right versus left amygdala protein expression in
control mice). In cases of two independent variables [e.g., genotype and
treatment (preformalin and postformalin)], two-way ANOVA with repeated measures was used followed by Bonferroni post hoc tests when
significant main effects were found. A value of p ⱕ 0.05 was considered
statistically significant for all statistical comparisons. All statistical comparisons were done with Prism 5 software (GraphPad).

Results
mGluR5 and activated ERK1/2 are expressed in the CeLC
We evaluated mGluR5 in the brains of WT and conventional
mGluR5 knock-out mice under naive conditions (Jia et al., 1998)
(Fig. 1 A). mGluR5 expression in WT mice is highest in the hippocampus, striatum, and a small section of the amygdala, but is
diffusely expressed throughout the parenchyma (Fig. 1 A, left).
No positive immunohistochemical signal was detected in the
brains of mGluR5 KO mice (Fig. 1 A, right). In WT mice, mGluR5

Baseline withdrawal sensitivity measurements were performed in
WT mice, and 1 day later either DHPG (0.1 or 0.01 nmol) or
vehicle was infused into the right amygdala via a preimplanted
cannula (0.3 l over a 3 min period). Withdrawal to mechanical
stimulation was assessed 30 min postinfusion. Infusion of DHPG
into the CeA significantly decreased mechanical withdrawal
thresholds in both hindpaws (Fig. 2 A, B) compared with baseline
values and postvehicle thresholds.
Previous work has found that intracellular signaling cascades
critical to the modulation of mechanical hypersensitivity are
functionally lateralized to the right amygdala (Carrasquillo and
Gereau, 2007, 2008). To test whether this was also true for group
I mGluRs, we next examined the effects of left amygdala DHPG
infusion (0.1 nmol) on mechanical withdrawal thresholds.
Whereas right amygdala infusion of DHPG induced bilateral hypersensitivity, we found that left amygdala infusion induced hypersensitivity in only the contralateral (right) hindpaw (Fig. 2C,D).
Subsequently, our studies focused on manipulations of the
right amygdala because previous work from our laboratories
(Carrasquillo and Gereau, 2007, 2008) and others (Ji and Neugebauer, 2009) has shown that pain-related right CeA activation
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B

cessity of mGluR5 in DHPG-induced mechanical hypersensitivity.

mGluR5 activation in the right
amygdala results in ERK1/2 activation
Thus far, we have demonstrated that
mGluR5 activation in the amygdala is sufficient to induce mechanical hypersensitivity in uninjured mice. To evaluate the
downstream signaling components of
mGluR5 activation in the amygdala, we
D
C
tested whether group I mGluR activation
would induce ERK1/2 activation. Representative sections show activated ERK1/2
in the amygdala of mice infused with
DHPG (0.1 nmol) or vehicle into the right
amygdala (Fig. 4A). In a separate cohort of
mice, animals were injected with either
DHPG (0.1 nmol) or vehicle alone and
evaluated by Western blotting for amygdalar ERK1 or ERK2 activation (Fig. 4 B).
Quantification revealed that right amygFigure 3. mGluR5 is required for intra-amygdala DHPG-induced mechanical hypersensitivity. A, B, MPEP (an mGluR5 antago- dala DHPG infusion induced a signifinist) (0.001 nmol, n ⫽ 6; 0.01 nmol, n ⫽ 6), but not vehicle (n ⫽ 7), coinfused with DHPG (0.1 nmol) into the right amygdala
cant increase in ERK1 (pERK1/totalERK1
blocks mechanical hypersensitivity induced by DHPG in the left (A) and right (B) paws. C, D, DHPG injected in the right amygdala
expressed as fold control left amygdala)
KO
induces mechanical hypersensitivity in WT mice (n ⫽ 6) but not mGluR5 mice (n ⫽ 5). Baseline withdrawal thresholds in
mGluR5 KO mice are higher than those of control mice. Gray area in brain illustration is representative of WT mGluR5 expression; (Fig. 4C) and ERK2 activation (pERK2/
white area in brain illustration is representative of where mGluR5 is deleted. Data are expressed as mean ⫾ SEM. Repeated- totalERK2 expressed as fold control left
measures ANOVA with Bonferroni post-test: *p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001, compared with vehicle plus DHPG-treated amygdala) (Fig. 4 D) in the right amygdala
group (A, B) or mGluR5 WT mice (C, D) at specified time point; ##p ⬍ 0.01, ###p ⬍ 0.001, compared with baseline for specified compared with samples taken from the
group.
left amygdala of DHPG-injected mice and
samples from vehicle-injected animals.
occurs independently of the side of injury. To determine whether
Given that ERK1/2 is activated by DHPG, we next asked
the effects of right amygdala DHPG were due to specific activawhether ERK activation might be necessary for the observed right
tion of mGluR5, the noncompetitive mGluR5 antagonist MPEP
amygdala DHPG-induced mechanical hypersensitivity. DHPG
(0.001 nmol or 0.01 nmol) was coinfused with DHPG (0.1 nmol)
(0.1 nmol in aCSF) was coinfused into the right amygdala of WT
into the right amygdala of WT mice before testing. Mice coinmice with either a MEK1/2 inhibitor (U0126; 1.5 nmol in DMSO)
fused with 0.01 nmol of MPEP and DHPG exhibited no changes
or an inactive control analog (U0124; 1.5 nmol in DMSO) 30 min
from baseline and significantly higher mechanical withdrawal
before von Frey behavioral testing. DHPG infusion resulted in
thresholds in both hindpaws than did mice coinfused with vehisignificantly decreased paw withdrawal thresholds, which were
cle and DHPG (Fig. 3 A, B). The effects of MPEP were dose departially reversed by coinfusion with U0126 but not the inactive
pendent, as 0.001 MPEP coinfused with DHPG failed to inhibit
analog U0124 (Fig. 4 E, F ). At this dose of U0126, we have previDHPG-induced hypersensitivity. In a separate experiment,
ously shown no differences in mechanical sensitivity between
MPEP (0.01 nmol) alone did not significantly affect withdrawal
U0126- and vehicle-treated mice (Carrasquillo and Gereau,
thresholds compared with those of vehicle-treated mice (left paw
2007), suggesting that the observed effects of U0126 on DHPGwithdrawal threshold: vehicle n ⫽ 6 0.43 ⫾ 0.07 g vs 0.01 nmol of
induced mechanical hypersensitivity are not caused by U0126MPEP n ⫽ 5 0.35 ⫾ 0.05 g; Student’s t test, p ⫽ 0.41; right paw
mediated alterations in baseline sensitivity in the absence of
withdrawal threshold: vehicle n ⫽ 6 0.39 ⫾ 0.06 g vs 0.01 nmol of
DHPG.
MPEP n ⫽ 5 0.39 ⫾ 0.07 g; Student’s t test, p ⫽ 0.99). This
Following behavioral testing, we evaluated whether MEK1/2
suggests that the effects of MPEP on DHPG-induced hypersensiinhibition with U0126 would block DHPG-induced ERK1/2 activity are not attributable to MPEP-induced alterations in metivation. ERK1 and ERK2 activation after DHPG coinfusion with
chanical sensitivity in the absence of DHPG. Together, all of these
either U0124 or U0126 is shown in a representative Western blot
results demonstrate the necessity of amygdala mGluR5 in
(Fig. 4G). Quantification revealed that DHPG-induced ERK1/2 acDHPG-induced mechanical hypersensitivity.
tivation in the right amygdala was significantly decreased with coinIn addition to pharmacological testing, we used mGluR5 KO
fusion of U0126 compared with coinfusion of U0124 (Fig. 4H).
mice to test for the necessity of mGluR5 in DHPG-induced mechanical hypersensitivity. Baseline withdrawal thresholds were
Pharmacological blockade of mGluR5 inhibits formalinhigher in mGluR5 KO mice compared with those of WT litterinduced behavioral hypersensitivity and ERK1/2 activation
mates (Fig. 3C,D). Following baseline testing, DHPG (0.1 nmol)
We have demonstrated that activation of mGluR5 in the amygwas infused into the right amygdalas of all mice. Whereas infudala is sufficient to induce peripheral mechanical hypersensitivity
sion of DHPG induced robust bilateral hypersensitivity in WT
in the absence of any injury or painful stimulus. We next sought
mice, we found that infusion of DHPG into mGluR5 KO mice
to test the hypothesis that activation of mGluR5 in the right
failed to induce any significant mechanical hypersensitivity in
amygdala is necessary for the full expression of nociceptive beeither paw (Fig. 3C,D). Overall, these data demonstrate the ne-
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havior following formalin-induced peripheral inflammation (Fu et al., 2001;
Carrasquillo and Gereau, 2007).
To test whether blocking mGluR5 activation in the right amygdala has an effect
on this nociceptive response, WT mice
were given right paw intraplantar injections of formalin (2% in saline) and 2 h
later were treated with either MPEP (0.01
nmol) or vehicle via right intra-amygdala
infusion. In all animals tested, withdrawal
thresholds to mechanical stimuli in both
paws were significantly reduced 1 h after
formalin injection. At 3 h, mechanical
withdrawal thresholds after MPEP infusion were significantly higher in both
paws compared with withdrawal thresholds in vehicle-infused mice (Fig. 5 A, B).
Furthermore, MPEP infusion significantly
increased withdrawal thresholds in both
paws compared with 1 h postformalin values and returned withdrawal thresholds
in the noninjected (left) paw to a level that
was not significantly different from the
preformalin baseline (Fig. 5A). These results suggest that mGluR5 in the CeA is
necessary for the full behavioral response
to intraplantar formalin.
Previous work has demonstrated that
formalin induces a selective activation of
ERK1/2 in the right CeLC (Carrasquillo
and Gereau, 2007). To test whether
mGluR5 activation in the right amygdala
is necessary for this inflammation-induced
change, we evaluated formalin-induced
ERK1/2 activation following amygdalar infusion of MPEP or vehicle. WT mice were
given right paw intraplantar injections of
formalin and 2 h later were administered
with either MPEP (0.01 nmol) or vehicle via
right intra-amygdala infusion. Comparing
the right amygdala between the two groups,
we found a significant decrease in ERK1 and
ERK2 activation 3 h after formalin in the
MPEP-treated group compared with the vehicle group (Fig. 5C,D), suggesting that
mGluR5 is necessary for formalin-induced
ERK1/2 activation in the amygdala.
Although mGluR5 inhibition in the
right amygdala was sufficient to reverse
formalin-induced mechanical hypersensitivity, we also tested whether blocking
mGluR5 activation in the left amygdala
might have an effect on this nociceptive
response. WT mice were given right paw
intraplantar injections of formalin (2% in
saline) and treated 2 h later with either
MPEP (0.01 nmol) or vehicle via left
intra-amygdala infusion. In all animals
tested, withdrawal thresholds to mechanical stimuli in both paws were significantly
reduced at both 1 and 3 h after formalin
injection (Fig. 5 E, F ). Interestingly, in
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Figure 4. DHPG and ERK activation in the amygdala. A, Representative sections showing immunofluoresence (white) for phosphorylatedERK1/2intheamygdala[whitedotted-line:top,0.1nmolofDHPGinjected30minbeforekill;bottom,vehicle(aCSF)injected30min
before kill]. B, Representative Western blot showing phosphorylated (Phospho) ERK1 and ERK2 bands (top) and total ERK1 and ERK2
(bottom) from mice injected in the right amygdala (Amy) with either vehicle (n ⫽ 8) or DHPG (0.1 nmol, n ⫽ 8) before being killed. C, D,
Quantification of Western blots showing increased activation of ERK by DHPG compared with vehicle. C, Activated ERK1 is increased in the
right amygdala of DHPG-treated mice compared with the left amygdala of DHPG-injected mice and vehicle-injected right amygdala
samples.D,ActivatedERK2isincreasedintherightamygdalaafterDHPGinjectioncomparedwithleftamygdalaofDHPG-injectedmiceand
vehicle-injectedrightamygdalasamples.E,F,Rightamygdalacoinfusionof0.1nmolofDHPGwiththeMEK1/2inhibitorU0126(1.5nmol,
n⫽6)inducesreducedmechanicalhypersensitivitycomparedwithcoinfusionofDHPGplusU0124(inactivecontrolanalogofU0126,n⫽
5) in both the left (E) and right (F) paws. G, Representative Western blot showing phosphorylated ERK1 and ERK2 bands (top) and total
ERK1 and ERK2 (bottom blot) from mice injected in the right amygdala with DHPG and U0124 (n ⫽ 5) or DHPG and U0126 (n ⫽ 6) before
being killed. H, Quantification of right amygdala tissue sample Western blot showing reduced ERK1 and ERK2 phosphorylation in mice
injected with U0126 plus DHPG compared with mice injected with U0124 plus DHPG. Gray area in brain illustration is representative of WT
mGluR5 expression. Scale bars, 200 m. Data are expressed as mean ⫾ SEM. Graphs of Western data are normalized to control left
amygdala protein expression. Repeated-measures ANOVA with Bonferroni post-test: *p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001, compared
with specified sample (C, D) or other group at indicated time point (E, F); #p ⬍ 0.05, ##p ⬍ 0.01, ###p ⬍ 0.001, compared with baseline
for specified group; unpaired Student’s t test: ⴙp ⬍ 0.05.
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Figure 5. mGluR5 activation is necessary for formalin-induced mechanical hypersensitivity and ERK1/2 activation. A–F, Mice
are injected in the right paw with formalin at time 0 min. A, B, Intra-right amygdala MPEP (0.01 nmol, n ⫽ 6 at 120 min) reverses
mechanical hypersensitivity in the noninjected paw (A) and reduces hypersensitivity in the injected paw (B) compared with
predrug measurements (at 60 min) and baseline values. In addition, MPEP-treated mice exhibit increased withdrawal thresholds
compared with those of intra-right amygdala vehicle-treated mice (n ⫽ 6). C, D, Intra-right amygdala MPEP (0.01 nmol at 120 min
after intraplantar formalin) reverses formalin-induced ERK1/2 activation in the right amygdala (Amy). C, Representative Western
blot showing phosphorylated ERK1 and ERK2 bands (top) and total ERK1 and ERK2 (bottom) from mice injected in the right
amygdala with MPEP (n ⫽ 8) or vehicle (n ⫽ 8) 60 min before kill (180 min after intraplantar formalin). D, Quantification of right
amygdala tissue sample Western blots showing reduced ERK1 and ERK2 phosphorylation in mice injected with MPEP compared
with samples from mice injected with vehicle. E, F, Intra-left amygdala MPEP (0.01 nmol, n ⫽ 5 at 120 min) does not reverse
mechanical hypersensitivity in either the noninjected (E) or injected paw (F ). Furthermore, left-amygdala MPEP-treated mice do
not exhibit different withdrawal thresholds compared with those of intra-left amygdala vehicle-treated mice (n ⫽ 6) at any time
point after formalin injection. Gray areas in brain illustrations are representative of WT mGluR5 expression. Data are expressed as
mean ⫾ SEM. Graphs of Western data are normalized to control left amygdala protein expression. Repeated-measures ANOVA
with Bonferroni post-test: ***p ⬍ 0.001, compared with vehicle-treated group at specified time point; #p ⬍ 0.05, ###p ⬍ 0.001,
compared with baseline for specified group; unpaired Student’s t test: ⴙⴙp ⬍ 0.01.

contrast to our results of MPEP infusion into the right amygdala,
MPEP infusion into the left amygdala did not induce changes in
withdrawal thresholds compared with vehicle-treated mice. Together, these results suggest that mGluR5 in the right CeA only is
necessary for the full mechanical behavioral response to intraplantar formalin.
Genetic disruption of mGluR5 blocks formalin-induced
mechanical hypersensitivity
The specific role for mGluR5 in formalin-induced mechanical
hypersensitivity was also verified by testing mGluR5 KO mice and
WT littermates in the von Frey test. In accordance with our base-

line results above, withdrawal thresholds for
mGluR5 KO mice were significantly greater
than those of WT littermates in the right
paw (Fig. 6B). Interestingly, intraplantar
formalin induced mechanical hypersensitivity in both hindpaws of WT mice but
only in the injected (right) hindpaw of
mGluR5 KO mice (Fig. 6A,B). Furthermore,
withdrawal thresholds of mGluR5 KO mice
were significantly greater than those of WT
littermates for both paws 3 h after formalin
injection.
To confirm deletion of mGluR5 in
mGluR5 KO mice, amygdala tissue was
probed for mGluR5 expression using Western blotting. Representative blots in Figure
6C clearly show an absence of mGluR5 signal in KO mice compared with WT littermates. In addition, as ERK is preferentially
activated in the right amygdala of WT mice
during inflammation (Carrasquillo and Gereau, 2007, 2008), WT amygdala samples
were probed to see whether mGluR5 protein expression might differ between the left
and right amygdalas. mGluR5 expression is
significantly higher in the right amygdala
relative to the left (Fig. 6C) (paired Student’s
t test p ⫽ 0.021). We also tested to see
whether there might be a lateralization of
total ERK1/2 in the amygdala of WT and
mGluR5 KO mice. Comparing right amygdala ERK1 or ERK2 expression relative to
left amygdala expression, we found no significant lateralization of either isoform for
either genotype and no differences between
genotypes (data not shown).

Targeted disruption of amygdalar
endocrine feedback does not
inhibit formalin-induced
mechanical hypersensitivity
An important question in understanding
the amygdala’s role in processing persistent
inflammatory pain is whether nociceptive
behavior is influenced by endocrine inputs
to the amygdala. A component of the physiological response to formalin in mice is an
activation of the hypothalamic-pituitaryadrenal (HPA) axis leading to an increase
in circulating glucocorticoids (e.g., corticosterone) (Vissers et al., 2003, 2004),
which can bind GRs in the amygdala to induce cellular changes.
With regard to the present study, corticosterone and the HPA
axis have been linked to mGluR5 and pain-related cellular and
behavioral changes (Greenwood-Van Meerveld et al., 2001;
Bradbury et al., 2003). As such, we wanted to know whether GR
disruption in the amygdala would influence long-lasting mechanical hypersensitivity induced by persistent inflammation. As
previously reported, lentiviral-mediated conditional CeAspecific GR knock-out (GR CeAKO) mice have GRs disrupted in
60 –75% of neurons compared with control mice (Kolber et al.,
2008). Here, mechanical thresholds were evaluated at baseline
and 3 h after right hindpaw formalin injection in GR CeAKO and
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control mice. Formalin injection resulted
in a significant reduction in mechanical
sensitivity in both paws of GR CeAKO and
control mice. There were no significant
differences between genotypes at any time
point (Fig. 6 D, E). These data suggest that
GR expression in the CeA (and therefore
endocrine feedback onto CeA neurons) is
not necessary for formalin-induced mechanical hypersensitivity.
Disruption of mGluR5 in the right
amygdala reduces inflammatory pain
Both pharmacological inhibition of mGluR5
and global disruption of mGluR5 expression reduce inflammatory pain. Furthermore, mGluR5 expression is expressed at
higher levels in the right amygdala relative
to the left amygdala. These data are consistent with the hypothesis that mGluR5
activation in the right amygdala is critical
to the behavioral response to formalininduced inflammation. To further test
this hypothesis, a conditional knock-out
approach was used to disrupt mGluR5 selectively in the right amygdala. Mice homozygous for the floxed-mGluR5 allele or
WT littermates were injected into the right
amygdala with recombinant lentivirus expressing Cre recombinase (LV-Cre). Floxed
normal formalin-induced mechanical hypersensitivity.
mGluR5 mice injected with LV-Cre Figure 6. Genetic disruption of mGluR5 but not GR expression prevents
A, B, In response to right paw formalin-injection, conventional mGluR5 KO mice (n ⫽ 9) show no hypersensitivity in the left paw
CeAKO
(mGluR5
) exhibited a significant decompared with baseline and reduced hypersensitivity in both paws compared with WT mice (n ⫽ 7) (A). mGluR5 KO mice show
crease in mGluR5 expression in the right increased basal withdrawal responses in the right paw compared with wild-type mice (B). C, Representative Western blots for
amygdala compared with the right amyg- mGluR5 (top) and ␤-tubulin (bottom) in mGluR5 KO mice and WT mice. Quantification of Western blot shows no mGluR5 expresdala of LV-Cre-injected WT (control) mice sion in mGluR5 KO mice (n ⫽ 7) and significantly higher mGluR5 expression in right amygdala (Amy) relative to left amygdala in WT
(unpaired Student’s t test p ⫽ 0.01) (Fig. mice (n ⫽ 7). D, E, Deletion of GR bilaterally (GR CeAKO, n ⫽ 9) does not induce any behavioral changes under basal conditions or
7A). Similar to WT mice above, control LV- following right paw formalin injection in the noninjected (left) (D) or injected (E) (right) paw compared with control vectorCre-injected mice exhibited significantly injected mice (control, n ⫽ 9). White area in top brain illustration is representative of areas where mGluR5 is disrupted; blue area
higher mGluR5 expression in the right in bottom brain illustration is representative of areas of WT GR expression; white area in bottom brain illustration is representative
amygdala relative to the left amygdala of disruption of GR bilaterally in the CeA. Data are expressed as mean ⫾ SEM. Graphs of Western data are normalized to control left
ANOVA with Bonferroni post-test: **p ⬍ 0.01, ***p ⬍ 0.001, compared with
(paired Student’s t test p ⫽ 0.049) (Fig. 7A). amygdala protein expression. Repeated measures
control genotype at specified time point; #p ⬍ 0.05, ##p ⬍ 0.01, ###p ⬍ 0.001, compared with same genotype at baseline; paired
To address whether the observed decrease in
Student’s t test: ⫹p ⬍ 0.05.
mGluR5 expression (in mGluR5 CeAKO
mice) was specific or reflected an overall deintraplantar formalin injection. In the von Frey test at baseline,
crease in protein expression in amygdala tissue, we evaluated GR
mGluR5 CeAKO mice exhibited no significant differences in meexpression. No differences in amygdala GR expression were found
chanical withdrawal thresholds compared with those of control
between mGluR5 CeAKO and control mice, and no significant latermice (Fig. 7 D, E). However, 3 h after formalin injection,
alization of GR was found in either genotype (Fig. 7B).
mGluR5 CeAKO mice exhibited increased mechanical withdrawal
To examine the behavioral effects of right amygdala mGluR5
thresholds in the von Frey Test compared with thresholds of
disruption, we measured spontaneous formalin-induced behavcontrol mice (Fig. 7 D, E). When compared with baseline values,
CeAKO
ior in mGluR5
and control mice. In addition to changes to
injection of formalin induced significant mechanical hypersensimechanical sensitivity, intraplantar formalin injection induces a
tivity in both hindpaws of control LV-Cre mice (Fig. 7 D, E) but
stereotyped biphasic, spontaneous behavioral response in the
only induced significant hypersensitivity in the injected (right)
first 60 min following injection (Tjolsen et al., 1992). Convenhindpaws of mGluR5 CeAKO mice (Fig. 7E). Overall, these data
tional global mGluR5 KO mice have a decreased second phase of
suggest that mGluR5 expression in the right amygdala is necesthis response (Montana et al., 2009). In contrast, we found no
sary for normal formalin-induced hypersensitivity.
CeAKO
significant differences between mGluR5
and control mice
in either the first phase (control: n ⫽ 4, 267.3 ⫾ 32.73 s;
Discussion
mGluR5 CeAKO: n ⫽ 3, 254.7 ⫾ 34.67; p ⫽ 0.81) or second phase
The findings of this study provide a mechanistic framework for
(control: n ⫽ 4, 709.8 ⫾ 39.89 s; mGluR5 CeAKO: n ⫽ 3, 685.3 ⫾
44.46; p ⫽ 0.48) of spontaneous behavior testing (Fig. 7C).
the emerging role of the amygdala in the modulation of persistent
Next, we examined mechanical sensitivity in mGluR5 CeAKO
pain due to peripheral inflammation. We demonstrate that
mice and control mice under baseline conditions and following
mGluR5 activation in the amygdala is sufficient to induce me-
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conditions, such as those seen after intraplantar formalin injection. mGluR5 is
necessary for the full expression of central
sensitization and the exhibition of second
phase nociceptive behaviors in the spontaneous formalin test (Bhave et al., 2001;
Karim et al., 2001a; Adwanikar et al.,
2004; Montana et al., 2009). Intraplantar
formalin injection also induces persistent
hypersensitivity to mechanical and thermal stimuli (Fu et al., 2001; Carrasquillo
C
D
E
and Gereau, 2007). Interestingly, global
mGluR5 disruption reduces but does not
eliminate mechanical hypersensitivity in
the formalin-injected paw. The observed
reduction is only partial due to ongoing
local inflammation at the site of formalin
injection and resultant peripheral sensitization. However, a caveat of this finding is
the demonstration that mGluR5 KO mice
Figure 7. Conditional deletion of mGluR5 in the right amygdala prevents formalin-induced mechanical hypersensitivity. A, exhibit a reduced acute behavioral reRepresentative Western blot for mGluR5 (top) and ␤-tubulin (bottom) in mGluR5 CeAKO and WT LV-Cre (control) mice. Graph of sponse to formalin injection in the paw
mGluR5/␤-tubulin shows reduced mGluR5 expression in the right amygdala of mGluR5 CeAKO mice (n ⫽ 6) [compared with the (Montana et al., 2009) and hyporesponright amygdala of control mice (n ⫽ 6)]. The graph also shows significantly higher mGluR5 expression in the right amygdala siveness to mechanical stimulation under
relative to the left amygdala in control mice. B, Representative Western blot for glucocorticoid receptor (top) and ␤-tubulin baseline conditions. The observation that
(bottom) in mGluR5 CeAKO mice and control mice. Graph shows no differences between mGluR5 CeAKO or control mice in GR expres- mGluR5 antagonists do not alter basesion in the right or left amygdala and no lateralization of GR expression in either genotype. C, mGluR5 CeAKO mice show equivalent
line mechanical sensitivity in naive mice
spontaneous behavior (lifting, licking, scratching of injected paw) following formalin injection compared with that of control mice.
(Walker
et al., 2001) suggests that our obD, E, Disruption of mGluR5 in the right CeA leads to a complete block of hypersensitivity in the noninjected (left) paw (D) and
served
baseline
differences in mGluR5 KO
reduced hypersensitivity in the injected (right) paw (E) after formalin injection and reduced hypersensitivity in both paws compared with control mice. Gray area in brain illustration is representative of WT mGluR5 expression; white area in brain illustration mice are likely a result of compensatory
is representative of mGluR5 disruption in the right CeA. Data are expressed as mean ⫾ SEM. Graphs of Western data are normalized changes associated with global deletion of
to control left amygdala protein expression. Repeated-measures ANOVA with Bonferroni post-test: ***p ⬍ 0.001 compared with mGluR5.
control genotype at specified time point; ##p ⬍ 0.01, ###p ⬍ 0.001 compared with same genotype at baseline; paired Student’s
To circumvent these issues, we develt test: ⫹p ⬍ 0.05; unpaired Student’s t test: ⫹⫹p ⫽ 0.01.
oped a mouse with unilateral CeA-specific
deletion of mGluR5 (mGluR5 CeAKO) by
chanical hypersensitivity in the absence of injury and that
injecting the CeA of mice carrying floxed mGluR5 alleles (Xu et
mGluR5 activation is necessary for the development of mechanal., 2009) with a Cre recombinase-expressing lentivirus (Kolber et
ical hypersensitivity in response to inflammation. Furthermore,
al., 2008). These mGluR5 CeAKO mice had ⬃40 –50% reduction in
mGluR5 expression in the right amygdala compared with control
we provide evidence for hemispheric lateralization of amygdala
mice. This value may be an underestimate of disruption of
function and mGluR5 expression. In addition, we find that
mGluR5 in these mice due to the possible expression of mGluR5
mGluR5-related effects are linked to ERK1/2 activation in the
in glial cells (Ferraguti et al., 2001). The observed reduction in
amygdala. These results support the hypothesis that mGluR5 sigmGluR5 protein expression does not reflect a nonspecific denaling via ERK phosphorylation in the right amygdala plays an
crease in protein expression, as mGluR5 CeAKO mice express
important role in the neuromodulation of persistent pain.
equivalent amounts of GR protein compared with controls.
Interestingly, we demonstrate that activation of group I
mGluR5 CeAKO mice show significant reduction in formalinmGluRs in the right amygdala is sufficient to induce bilateral
induced mechanical hypersensitivity, but no changes in baseline
mechanical hypersensitivity. This result is of particular relevance
sensitivity or spontaneous responses to formalin injection. These
to pain conditions that exist in humans that do not have a
data are consistent with previous work showing that the amygknown underlying etiology (e.g., fibromyalgia). As both
dala is not involved in baseline nociception (Manning and
mGluR1 and mGluR5 are expressed in the amygdala, we
Mayer, 1995b; Carrasquillo and Gereau, 2007) or acute formalin
sought to clarify the necessity for mGluR5 in DHPG-induced
responses (Manning and Mayer, 1995a; Carrasquillo and Gereau,
hypersensitivity. Disruption of mGluR5 (pharmacologically
2007).
or genetically) significantly reduces the effects of DHPG.
To further test whether mGluR5 in the amygdala is necesThese data suggest that mGluR5 activation alone in the right
sary for prolonged mechanical hypersensitivity, we used a
amygdala is sufficient to induce mechanical hypersensitivity
pharmacological approach in WT mice to block mGluR5 in
but do not preclude a role for mGluR1 signaling in the amygthe right amygdala after formalin paw injection. We found
dala during nociceptive processing.
that formalin-induced mechanical hypersensitivity was reThe amygdala is involved in both ascending and descending
duced after right CeA MPEP infusion in a manner similar to
components of nociceptive pathways (Bernard et al., 1989). Nothat seen with global mGluR5 KO mice, consistent with the findciceptive input to the CeA via the spino-parabrachio-amygdaloid
ing that group I mGluR antagonists in the amygdala can inhibit
pathway or the BLA may provide a source of glutamatergic inputs
pain-like behaviors (Han and Neugebauer, 2005). In addition,
to the CeLC (Neugebauer et al., 2004). As such, the amygdala is
MPEP reversed hypersensitivity that had already developed beuniquely situated to modulate behavior during prolonged pain
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fore intra-amygdala drug infusions, suggesting that mGluR5 activation in the amygdala may be involved in the maintenance of
persistent pain-like behavior.
Our data indicate that some aspects of mGluR5 modulation of
pain-like behavior are lateralized to the right amygdala. We find a
higher level of mGluR5 expression in the right amygdala compared with expression in the left amygdala under normal conditions. These findings are not without precedent, as hemispheric
lateralization of amygdala function has been reported in both
humans (Coghill et al., 2001; Cahill et al., 2004; Lu et al., 2004;
Alkire et al., 2008) and rodents (Lalumiere and McGaugh, 2005;
Ji and Neugebauer, 2009). Previously, we established that during
formalin-induced inflammation, there is a selective activation of
ERK1/2 in the right CeLC that can be blocked with the MEK1/2
inhibitor U0126 (Carrasquillo and Gereau, 2008). In addition,
recent data show hemispheric lateralization of amygdala sensitization in arthritis (Ji and Neugebauer, 2009). Interestingly, in
that study, neurons of the right CeLC showed whole-body receptive fields, while left CeLC neurons showed more restricted contralateral receptive fields. Our observation of baseline differences
in mGluR5 protein reflects either more mGluR5 protein per cell
in the right amygdala or expression of mGluR5 in an additional
population of cells in the right amygdala relative to the left. Although future studies will be needed to clarify this issue, the data
showing larger receptive fields of right amygdala neurons (Ji and
Neugebauer, 2009), our data showing that DHPG infusion in the
right amygdala induced bilateral tactile hypersensitivity whereas
DHPG infusion in the left amygdala induced mechanical hypersensitivity in the right (contralateral) paw only, and our data
showing that MPEP could reverse formalin-induced mechanical
hypersensitivity when infused into the right but not left amygdala
suggest that there may be a unique population of cells in the right
amygdala that have bilateral connections within the CNS.
Three lines of evidence suggest that amygdalar mGluR5 is
functionally coupled to ERK and that this signaling pathway is
involved in endogenous pain modulation. First, we show that
activation of mGluR5 in the right amygdala induces activation of
ERK1/2. Second, we demonstrate that the behavioral effects of
DHPG can be reduced following coinfusion with the MEK inhibitor U0126. Finally, we show that mGluR5 inhibition in the right
amygdala blocks formalin-induced ERK1/2 activation in the
right amygdala. In the CeA, ERK1/2 is both necessary and
sufficient for formalin-induced mechanical hypersensitivity
(Carrasquillo and Gereau, 2007, 2008). In the spinal cord dorsal
horn, mGluR5-induced ERK activation modulates both spontaneous behavioral responses to formalin and neuronal excitability
via increasing ion channel phosphorylation (Karim et al., 2001a;
Hu and Gereau, 2003; Hu et al., 2007). Additional studies will be
necessary to determine whether similar mechanisms are responsible for DHPG-induced modulation of behavior at the level of
the amygdala. Interestingly, coinfusion of DHPG with the MEK
inhibitor U0126 caused only a partial reversal of DHPG-induced
mechanical hypersensitivity. These data suggest signaling pathways unrelated to ERK may be involved in mGluR5-related behavioral changes.
During stressful events, including formalin injection (Vissers
et al., 2003, 2004), the HPA axis is activated causing the release of
corticosterone, which binds to GR. Corticosterone-induced activation of amygdalar GR can increase colorectal distension-induced,
pain-related responses in rats (Greenwood-Van Meerveld et al.,
2001). Furthermore, systemic MPEP induces HPA axis activation,
suggesting the possible presence of a functional coupling of mGluR5
and the endocrine stress response (Bradbury et al., 2003). To test the

hypothesis that amygdalar GR is playing an underlying role in
formalin-induced mechanical hypersensitivity, we evaluated this behavior after bilateral conditional knock-out of GR in the CeA. We
found no differences in formalin-induced mechanical hypersensitivity in these GR CeAKO mice, although it is possible that the remaining population of GR-positive neurons was able to maintain normal
feedback during inflammatory pain. However, this is unlikely because we described previously a reduction in conditioned fear in
GR CeAKO mice with only 65% CeA GR disruption (Kolber et al.,
2008).
Overall, we show that CeA mGluR5 activation is both necessary for the development of inflammatory pain-like behavior and
sufficient to induce mechanical hypersensitivity in the absence of
injury. Furthermore, we demonstrate that the behavioral effects
of mGluR5 activation are mediated via ERK activation in the
CeA. In addition, we find hemispheric differences in mGluR5
expression and mGluR5 activation-induced behavior. Our results have important implications for understanding chronic
pain in human patients. Specifically, we identify mGluR5 as an
important cellular component of amygdala pain modulation,
which may provide a molecular connection to the known efficacy
of cognitive and behavioral approaches to pain treatment in human patients; our results demonstrate a specific anatomical location that may underlie some of the many preclinical studies
showing the potential efficacy of mGluR5 antagonists in the
treatment of pain.
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